Kumquat Biosciences Inc.
Clinical trials sponsored by Kumquat Biosciences Inc., explained in plain language.
-
New hope for advanced cancer: KQB198 trial launches
Disease control OngoingThis early-phase trial tests a new drug called KQB198 in adults with advanced solid tumors that have not responded to other treatments. The study aims to find a safe dose and see if KQB198 can shrink tumors when used alone or with other cancer drugs. About 100 participants will t…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New pill KQB198 tested for tough blood cancers
Disease control OngoingThis early-stage trial tests a new oral drug called KQB198, alone or with another drug (dasatinib), in 13 adults with advanced blood cancers that have not responded to prior treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. Participants tak…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC